FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to the field of diagnostics of infectious diseases and complications during the disease. A method is described for predicting the lethal outcome in patients with severe CoVID-19 by immunological examination of the parameters of macrophage inflammatory proteins MIP-1α and MIP-1β in blood serum, where when the concentration of MIP-1α above 70 pg/ml and MIP-1β above 50 pg/ml is reached, a high risk of the lethal outcome is predicted.
EFFECT: conducting a quick and affordable diagnosis makes it possible to timely select an adequate therapy.
1 cl, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CYTOKINE STORM ASSOCIATED WITH COVID-19 | 2022 |
|
RU2825710C2 |
| METHOD FOR PREDICTING THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795093C1 |
| METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2789426C1 |
| METHOD OF PREDICTING COMPLICATIONS AFTER COVID-19 IN PERSONS WITH COMORBID BACKGROUND IN THE ARCTIC REGION | 2023 |
|
RU2812780C1 |
| METHOD OF TREATING COVID-19 IN CHILDREN AT RISK OF SEVERE CLINICAL COURSE OF DISEASE | 2023 |
|
RU2815303C1 |
| METHOD FOR PREDICTING OUTCOMES OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795095C1 |
| METHOD FOR DIAGNOSING MACROPHAGE ACTIVATION SYNDROME IN A NEW CORONAVIRUS INFECTION CAUSED BY THE SARS VIRUS - COV-2 | 2022 |
|
RU2778779C1 |
| METHOD FOR PREDICTION OF OUTCOME OF ACUTE DISEASE CAUSED BY NEW CORONAVIRUS INFECTION COVID-19 | 2021 |
|
RU2766347C1 |
| METHOD FOR PREDICTING PROBABILITY OF DEATH IN PATIENTS WITH COVID-19 HOSPITALIZED ON BASIS OF LABORATORY AND INSTRUMENTAL STUDIES | 2023 |
|
RU2806726C1 |
